Immunization Newsbriefs
Link to Main Page
About NNiiParentsHealthcare ProfessionalsPolicy MakersPressroomPartners
Resources: Newsbriefs
Read Current Issue Online
Search Newsbriefs Archives
Subscribe to Email Online
Unsubscribe from Email Online

Vaccine Info Database

Search the Site

Send Your Feedbck
Read Current NewsbriefsBack

Getting Serious About Stopping STDs
Business Week Online;
Shook, David


Pharmaceutical and biotechnology companies are increasingly developing drugs and vaccines for sexually transmitted diseases (STDs) other than HIV. The success of AIDS drugs are helping the search by giving researchers time to work on other diseases and by providing a blueprint to follow. The U.S. market for a vaccine for a common STD could be over $1 billion annually. A potentially powerful vaccine for human papilloma virus helps make Merck the major player in STD treatments, although GlaxoSmithKline is also working on a vaccine for the disease.

© Copyright National Network for Immunization Information. The information contained in the National Network for Immunization Information Web site should not be used as a substitute for the medical care and advice of your health care provider. There may be variations in treatment that your health care provider may recommend based on individual facts and circumstances.